Received Nov 21, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | UNK | — |
Pain/tingling in the arm he received IZ. Shingles type blisters/rash.; Pain/tingling in the arm he received IZ. Shingles type blisters/rash.; Shingles type blisters/rash.; Shingles type blisters/rash.; This non-serious case was reported by a pharmacist via sales rep and described the occurrence of tingling in a elderly male patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received the 1st dose of Shingrix (unknown arm). On an unknown date, an unknown time after receiving Shingrix, the patient experienced tingling (Verbatim: Pain/tingling in the arm he received IZ. Shingles type blisters/rash.), pain in arm (Verbatim: Pain/tingling in the arm he received IZ. Shingles type blisters/rash.), blister (Verbatim: Shingles type blisters/rash.) and rash (Verbatim: Shingles type blisters/rash.). The outcome of the tingling, pain in arm, blister and rash were unknown. The reporter considered the tingling, pain in arm, blister and rash to be related to Shingrix. The company considered the tingling, pain in arm, blister and rash to be related to Shingrix. Additional Information: GSK Receipt Date: 19-NOV-2025 The reporter reported that the patient experienced pain and tingling in the arm he received vaccine. Shingles type blisters/rash. The batch number was not provided and a request for this information has been made.